Scientists have discovered that a modified form of a natural compound found in rosemary and sage may hold potential for ...
An oral small molecule from New York-based biotech Oligomerix curbed the tangling of tau protein in the brains of mice that ...
In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key ...
Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway ...
AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...
Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...
One of the world’s leading Parkinson’s disease scientists has warned of a potential pandemic of the neurological condition if research doesn’t “step up” to address the looming crisis.
Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung ...
A new international study has identified key genetic factors that may protect against Alzheimer’s disease (AD), offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results